Biotech Values

[DewDiligence]

AGN hits another all-time high, perhaps helped marginally by this story:

http://www.nejm.org/doi/full/10.1056/NEJMoa1200225

…we conclude that bariatric surgery represents a potentially useful strategy for management of uncontrolled diabetes, since it has been shown to eliminate the need for diabetes medications in some patients and to markedly reduce the need for drug treatment in others. In addition, among patients undergoing surgery, cardiovascular risk factors improved, allowing reductions in lipid-lowering and antihypertensive therapies.

Although the study in question did not include the LapBand device, the study’s conclusions are indirectly positive for the product, IMO.

Reuters newswire on the same story:
http://www.reuters.com/article/2012/03/26/us-heart-diabetes-bariatric-idUSBRE82P0QJ20120326